Absolute configuration of (-)-gambogic acid, an antitumor agent

Journal of Natural Products

Volumn 74, Issue 3, 2011, Pages 460-463

  Ren, Yulin ^a   Yuan, Chunhua ^a   Chai, Hee Byung ^a   Ding, Yuanqing ^b   Li, Xing Cong ^b   Ferreira, Daneel ^b   Kinghorn, A Douglas ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMBOGIC ACID; MORELLIC ACID; PACLITAXEL; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DEGRADATION; DRUG STRUCTURE; GARCINIA HANBURYI; HETERONUCLEAR MULTIPLE BOND CORRELATION; HETERONUCLEAR MULTIPLE QUANTUM COHERENCE; HUMAN; HUMAN CELL; MEDICINAL PLANT; NUCLEAR OVERHAUSER EFFECT; OPTICAL ROTATION; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET SPECTROSCOPY; X RAY DIFFRACTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG SCREENING ASSAYS, ANTITUMOR; GARCINIA; HT29 CELLS; HUMANS; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; RESINS, PLANT; STEREOISOMERISM; XANTHONES;

GARCINIA HANBURYI;

EID: 79953250107     PISSN: 01633864     EISSN: 15206025     Source Type: Journal    
DOI: 10.1021/np100422z     Document Type: Article

References (32)

1. Asano, J.; Chiba, K.; Tada, M.; Yoshii, T. Phytochemistry 1996, 41, 815-820.
2. Han, Q.-B.; Wang, Y.-L.; Yang, L.; Tso, T.-F.; Qiao, C.-F.; Song, J.-Z.; Xu, L.-J.; Chen, S.-L.; Yang, D.-J.; Xu, H.-X. Chem. Pharm. Bull. 2006, 54, 265-267.
3. Reutrakul, V.; Anantachoke, N.; Pohmakotr, M.; Jaipetch, T.; Sophasan, S.; Yoosook, C.; Kasisit, J.; Napaswat, C.; Santisuk, T.; Tuchinda, P. Planta Med. 2007, 73, 33-40.
4. Tao, S.-J.; Guan, S.-H.; Wang, W.; Lu, Z.-Q.; Chen, G.-T.; Sha, N.; Yue, Q.-X.; Liu, X.; Guo, D.-A. J. Nat. Prod. 2009, 72, 117-124.
5. Han, Q.-B.; Xu, H.-X. Curr. Med. Chem. 2009, 16, 3775-3796.It is stated on page 3781 of this comprehensive review that the absolute configuration of (-)-gambogic acid and its analogues remained undetermined at the time of publication.
6. Land, M.; Katz, A. Pharm. Acta Helv. 1949, 24, 387-401.
7. Ollis, W. D.; Ramsay, M. V. J.; Sutherland, I. O.; Mongkolsuk, S. Tetrahedron 1965, 21, 1453-1470.
8. Weakley, T. J. R.; Cai, S. X.; Zhang, H.-Z.; Keana, J. F. W. J. Chem. Cryst. 2001, 31, 501-505.On page 502 of this article, it is mentioned that the quality of the X-ray crystallographic data did not permit definition of the absolute configuration of (-)-gambogic acid.
9. Lin, L. J.; Lin, L. Z.; Pezzuto, J. M.; Cordell, G. A.; Ruangrungsi, N. Magn. Reson. Chem. 1993, 31, 340-347.
10. Cardillo, G.; Merlini, L. Tetrahedron Lett. 1967, 27, 2529-2530.
11. Han, Q.-B.; Yang, L.; Liu, Y.; Wang, Y.-L.; Qiao, C.-F.; Song, J.-Z.; Xu, L.-J.; Yang, D.-J.; Chen, S.-L.; Xu, H.-X. Planta Med. 2006, 72, 281-284.
12. Liu, W.; Guo, Q.-L.; You, Q.-D.; Zhao, L.; Gu, H.-Y.; Yuan, S.-T. World J. Gastroenterol. 2005, 11, 3655-3659.
13. Yang, Y.; Yang, L.; You, Q.-D.; Nie, F.-F.; Gu, H.-Y.; Zhao, L.; Wang, X.-T.; Guo, Q.-L. Cancer Lett. 2007, 256, 259-266.
14. Wu, Z.-Q.; Guo, Q.-L.; You, Q.-D.; Zhao, L.; Gu, H.-Y. Biol. Pharm. Bull. 2004, 27, 1769-1774.
15. Zhao, J.; Qi, Q.; Yang, Y.; Gu, H.-Y.; Lu, N.; Liu, W.; Wang, W.; Qiang, L.; Zhang, L.-B.; You, Q.-D.; Guo, Q.-L. Eur. J. Pharmacol. 2008, 589, 127-131.
16. Pandey, M. K.; Sung, B.; Ahn, K. S.; Kunnumakkara, A. B.; Chaturvedi, M. M.; Aggrawal, B. B. Blood 2007, 110, 3517-3525.
17. Qin, Y.-X.; Meng, L.-H.; Hu, C.-X.; Duan, W.-H.; Zuo, Z.-L.; Lin, L.-P.; Zhang, X.-W.; Ding, J. Mol. Cancer Ther. 2007, 6, 2429-2440.
18. Zhao, Q.; Yang, Y.; Yu, J.; You, Q.-D.; Zeng, S.; Gu, H.-Y.; Lu, N.; Qi, Q.; Liu, W.; Wang, X.-T.; Guo, Q.-L. Cancer Lett. 2008, 262, 223-231.
19. Yi, T.; Yi, Z.; Cho, S. G.; Luo, J.; Pandey, M. K.; Aggrawal, B. B.; Liu, M. Cancer Res. 2008, 68, 1843-1850.
20. Qi, Q.; You, Q.-D.; Gu, H.-Y.; Zhao, L.; Liu, W.; Lu, N.; Guo, Q.-L. J. Ethnopharmacol. 2008, 117, 433-438.
21. Zhou, Z. T.; Wang, J. W. Chin. J. New Drugs 2007, 16, 79-83.
22. Zhang, H.-Z.; Kasibhatla, S.; Wang, Y.; Herich, J.; Guastella, J.; Tseng, B.; Drewe, J.; Cai, S.-X. Bioorg. Med. Chem. 2004, 12, 309-317.
23. Kuemmerle, J.; Jiang, S.-C.; Tseng, B.; Kasibhatla, S.; Drewe, J.; Cai, S.-X. Bioorg. Med. Chem. 2008, 16, 4233-4241.
24. Chantarasriwong, O.; Cho, W. C.; Batova, A.; Chavasiri, W.; Moore, C.; Rheingold, A. L.; Theodorakis, E. A. Org. Biomol. Chem. 2009, 7, 4886-4894.
25. Nicolaou, K. C.; Sasmal, P. K.; Xu, H.; Namoto, K.; Ritzen, A. Angew. Chem., Int. Ed. 2003, 42, 4225-4229.
26. Nicolaou, K. C.; Sasmal, P. K.; Xu, H. J. Am. Chem. Soc. 2004, 126, 5493-5506.
27. Nicolaou, K. C.; Xu, H.; Wartmann, M. Angew. Chem., Int. Ed. 2005, 44, 756-761.
28. Hayden, A. E.; Xu, H.; Nicolaou, K. C.; Houk, K. N. Org. Lett. 2006, 8, 2989--2992.Although not a synthetic paper per se, this contribution discusses the origins of the selectivity of the appropriate pericyclic cascades via density functional theory (DFT) calculations.
29. Ren, Y.; Lantvit, D. D.; Carcache de Blanco, E. J.; Kardono, L. B. S.; Riswan, S.; Chai, H.; Cottrell, C. E.; Farnsworth, N. R.; Swanson, S. M.; Ding, Y.; Li, X.-C.; Marais, J. P. J.; Ferreira, D.; Kinghorn, A. D. Tetrahedron 2010, 66, 5311-5320.
30. El-Seedi, H. R.; El-Ghorab, D. M. H.; El-Barbary, M. A.; Zayed, M. F.; Göransson, U.; Larsson, S.; Verpoorte, R. Curr. Med. Chem. 2009, 16, 2581-2626.
31. Raghavan, S.; Rao, G. S. R. S. Heterocycles 1994, 37, 131-136.
32. Seo, E.-K.; Kim, N.-C.; Mi, Q.-W.; Chai, H.-B.; Wall, M.-E.; Wani, M. C.; Navarro, H. A.; Burgess, J. P.; Graham, J. G.; Cabieses, F.; Tan, G. T.; Farnsworth, N. R.; Pezzuto, J. M.; Kinghorn, A. D. J. Nat. Prod. 2001, 64, 1483-1485.